Skip to main content
    N

    Novanta Inc (NOVT)

    Official site

    TECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ

    $114.40
    -4.48 (-3.77%)

    Market Cap: $4.50B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Novanta Inc (NOVT) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Novanta (NOVT) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Novanta reported EPS of $1.05, above the $0.97 estimate. It beat the EPS estimate in each of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +15.96%
    Streak
    8 Q

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.98
    Range$0.91 - $1.07
    5 analysts
    Revenue Consensus
    $315.20M
    Range$302.13M - $325.11M
    5 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.87
    Range$0.87 - $0.87
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.98-11.2%
    60d ago$0.98-11.2%
    30d ago$0.98-11.2%
    7d ago$0.98-11.2%
    Current$0.87
    Revenue Consensus
    $318.90M
    Range$318.90M - $318.90M
    1 analysts

    Next Report

    NOVT has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 7.7% above the $0.91 reported for the quarter ended Dec 31, 2025.

    NOVT Earnings Call

    The latest NOVT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, NOVT beat 37 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $305.01M, up 23.1% from $247.84M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.05$0.97$0.96 - $0.97+8.25%Beat+20.7%32 up, 0 downNov 9, 2026$305.01M
    Jun 30, 2026$0.89$0.83$0.82 - $0.84+7.23%Beat+17.1%31 up, 2 downAug 5, 2026$265.81M
    Mar 31, 2026$0.81$0.78$0.76 - $0.79+3.85%Beat+9.5%30 up, 2 downMay 11, 2026$257.71M
    Dec 31, 2025$0.91$0.88$0.87 - $0.89+3.41%Beat+19.7%30 up, 1 downFeb 23, 2026$258.35M
    Sep 30, 2025$0.87$0.82$0.81 - $0.83+6.10%Beat+2.4%30 up, 1 downNov 3, 2025$247.84M
    Jun 30, 2025$0.76$0.73$0.73 - $0.74+4.11%Beat+4.1%30 up, 2 downAug 5, 2025$241.05M
    Mar 31, 2025$0.74$0.67$0.66 - $0.68+10.45%Beat0.0%30 up, 3 downMay 6, 2025$233.37M
    Dec 31, 2024$0.76$0.71$0.71 - $0.72+6.55%Beat+20.6%30 up, 2 downFeb 25, 2025$238.06M
    Sep 30, 2024$0.85$0.85$0.85 - $0.860.00%In line0.0%30 up, 0 downNov 5, 2024$244.41M
    Jun 30, 2024$0.73$0.69$0.69 - $0.70+5.80%Beat-8.8%30 up, 0 downAug 6, 2024$235.86M
    Mar 31, 2024$0.74$0.58$0.57 - $0.58+27.59%Beat0.0%30 up, 0 downMay 7, 2024$230.92M
    Dec 31, 2023$0.63$0.63$0.62 - $0.630.00%In line-16.0%30 up, 0 downFeb 28, 2024$211.57M
    Sep 30, 2023$0.85$0.74$0.74 - $0.75+14.86%Beat+4.9%30 up, 0 downNov 7, 2023$221.50M
    Jun 30, 2023$0.80$0.73$0.72 - $0.74+9.59%Beat+2.6%30 up, 0 downAug 8, 2023$229.46M
    Mar 31, 2023$0.74$0.64$0.64 - $0.65+15.63%Beat+1.4%30 up, 0 downMay 9, 2023$219.13M
    Dec 31, 2022$0.75$0.72$0.69 - $0.74+4.17%Beat+11.9%30 up, 0 downMar 1, 2023$218.37M
    Sep 30, 2022$0.81$0.74$0.73 - $0.75+9.46%Beat+8.0%40 up, 0 downNov 8, 2022$222.96M
    Jun 30, 2022$0.78$0.72$0.72 - $0.72+8.33%Beat+25.8%40 up, 0 downAug 9, 2022$215.36M
    Mar 31, 2022$0.73$0.63$0.62 - $0.64+15.87%Beat+25.9%40 up, 0 downMay 10, 2022$204.22M
    Dec 31, 2021$0.67$0.64$0.63 - $0.65+4.69%Beat+26.4%40 up, 0 downMar 1, 2022$198.96M
    Sep 30, 2021$0.75$0.60$0.59 - $0.61+25.00%Beat+78.6%4N/ANov 9, 2021$177.73M
    Jun 30, 2021$0.62$0.51$0.50 - $0.52+21.57%Beat+29.2%4N/AAug 10, 2021$167.52M
    Mar 31, 2021$0.58$0.39$0.38 - $0.41+48.72%Beat+13.7%4N/AMay 11, 2021$162.58M
    Dec 31, 2020$0.53$0.44$0.42 - $0.45+20.45%Beat-3.6%4N/AMar 1, 2021$147.50M
    Sep 30, 2020$0.42$0.39$0.38 - $0.42+7.69%Beat-20.8%3N/ANov 10, 2020$142.93M
    Jun 30, 2020$0.48$0.23$0.20 - $0.28+108.70%Beat-11.1%3N/AAug 6, 2020$144.73M
    Mar 31, 2020$0.51$0.32$0.25 - $0.39+59.38%Beat-3.8%3N/AMay 12, 2020$155.47M
    Dec 31, 2019$0.55$0.54$0.53 - $0.54+1.85%Beat-1.8%3N/AFeb 26, 2020$159.70M
    Sep 30, 2019$0.53$0.52$0.51 - $0.52+1.92%Beat-13.1%3N/ANov 5, 2019$154.07M
    Jun 30, 2019$0.54$0.54$0.54 - $0.540.00%In line+5.9%3N/AAug 6, 2019$155.15M
    Mar 31, 2019$0.53$0.48$0.48 - $0.49+10.42%Beat+12.8%3N/AMay 7, 2019$157.19M
    Dec 31, 2018$0.56$0.51$0.51 - $0.52+9.80%Beat+27.3%3N/AFeb 27, 2019$156.18M
    Sep 30, 2018$0.61$0.52$0.51 - $0.52+17.31%Beat+35.6%3N/ANov 6, 2018$160.79M
    Jun 30, 2018$0.51$0.49$0.48 - $0.49+4.08%Beat+24.4%3N/AAug 8, 2018$150.40M
    Mar 31, 2018$0.47$0.40$0.38 - $0.41+17.50%Beat+51.6%3N/AMay 8, 2018$146.97M
    Dec 31, 2017$0.44$0.41$0.40 - $0.41+7.32%Beat+25.7%3N/AFeb 28, 2018$146.92M
    Sep 30, 2017$0.45$0.34$0.34 - $0.34+32.35%Beat+55.2%1N/ANov 1, 2017$146.30M
    Jun 30, 2017$0.41$0.33$0.33 - $0.33+24.24%Beat+51.9%1N/AAug 3, 2017$119.10M
    Mar 31, 2017$0.31$0.24N/A+29.17%Beat+72.2%N/AN/AMay 8, 2017$108.97M
    Dec 31, 2016$0.35$0.28N/A+25.00%Beat+20.7%N/AN/AMar 6, 2017$98.88M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $3.28, up 6.5% from the year before. It was $1.09 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$3.28+6.5%
    Dec 31, 2024$3.08+2.0%
    Dec 31, 2023$3.02-1.6%
    Dec 31, 2022$3.07+17.2%
    Dec 31, 2021$2.62+35.1%
    Dec 31, 2020$1.94-9.8%
    Dec 31, 2019$2.15N/A
    Dec 31, 2018$2.15+33.5%
    Dec 31, 2017$1.61+47.7%
    Dec 31, 2016$1.09N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,7438
    2026Q2Jun 30, 20266,1509
    2026Q1Mar 31, 20267,2997
    2025Q4Dec 31, 20258,2727
    2025Q3Sep 30, 20256,1487
    2025Q2Jun 30, 20257,4097
    2025Q1Mar 31, 20257,1897
    2024Q4Dec 31, 20248,3197

    2026Q3 Earnings Call

    Opening remarks

    Marcella Meditz Corporate Finance Leader Thank you very much. Good morning, and welcome to Novanta's Third Quarter 2026 Earnings Conference Call. This is Marcella Meditz, Corporate Finance Leader for Novanta. With me on today's call is our Chair and Chief Executive Officer, Matthijs Glastra; our Chief Financial Officer, Robert Buckley; and our Co-Chief Operating Officers, Chuck Ravetto and John Lesica. If you have not received a copy of our earnings press release issued last night, you may obtain it from the Investor Relations section of our website at www.novanta.com. Please note, this call is being webcast live and will be archived on our website shortly after the call. Before we begin, we need to remind everyone of the safe harbor for forward-looking statements that we've outlined in our earnings press release issued last night and also those in our SEC filings. We may make some comments today, both in our prepared remarks and in our responses to questions, that may include forward-looking statements. These involve inherent assumptions with known and unknown risks and other factors that could cause our future results to differ materially from our current expectations. Any forward-looking statements made today represent our views only as of this time. We disclaim any obligation to update forward-looking statements in the future, even if our estimates change. You should not rely on any of these forward-looking statements as representing our views as of any time after this call. During this call, we will be referring to certain non-GAAP financial measures. A reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures is available as an attachment to our earnings press release. To the extent that we use non-GAAP financial measures during this call that are not reconciled to GAAP measures in the earnings press release, we will provide reconciliations promptly on the Investor Relations section of our website after this call. I am now pleased to introduce the Chair and Chief Executive Officer of Novanta, Matthijs Glastra.

    Matthijs Glastra Chair and CEO Thank you, Marcella. Good morning, everybody, and thanks for joining our call. The third quarter was a milestone quarter for Novanta. We closed the largest acquisition in our history, Riverpoint Medical, and at the same time delivered results ahead of expectations on revenue, adjusted EBITDA, and adjusted EPS. Revenue grew 23% on a reported basis to $305 million, with organic growth of nearly 10%, our strongest organic growth in more than three years. Adjusted EBITDA grew 38% to $80 million, or a 26% EBITDA margin, the highest in Novanta's history, and an expansion of 290 basis points year over year. Adjusted EPS grew 21% to $1.05.

    Frequently Asked Questions About NOVT

    When is Novanta's next earnings date?

    Novanta's next earnings report is expected for Feb 22, 2027.

    Did NOVT beat earnings estimates last quarter?

    Yes. Novanta reported EPS of $1.05 for the quarter ended Sep 30, 2026, above the $0.97 estimate, a 8.25% surprise.

    What EPS do analysts expect from NOVT next quarter?

    The consensus EPS estimate for Novanta for the quarter ending Dec 31, 2026 is $0.98 from 5 analysts, with estimates from $0.91 to $1.07.

    How often does NOVT beat earnings estimates?

    Novanta beat the EPS estimate in each of the last 8 quarters, with an average surprise of +6.24%.